Evidence map›Paper›PMID 23683829›Full record

ReviewInternational journal of radiation oncology, biology, physics2013

Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review.

Alysa Fairchild, William Straube, Fran Laurie, David Followill

Abstract readReview
In one paragraph

Review in International journal of radiation oncology, biology, physics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. A dedicated cloud system for real-time upfront quality assurance in pediatric radiation therapy.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2019
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Current practices in peer review in German radiation oncology: a nationwide survey.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial.Clinical and translational radiation oncology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alysa FairchildDepartment of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada. alysa.fairchild@albertahealthservices.ca
William Straube
Fran Laurie
David Followill

Funding

RADIOLOGICAL PHYSICS CENTERU10CA010953 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FOLLOWILL, DAVID S · 1985 to 2013
$34.5M
QUALITY ASSURANCE REVIEW CENTER (QARC)U10CA029511 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, THOMAS J. · 1985 to 2013
$23.4M
ADVANCED TECHNOLOGY QA CENTERU24CA081647 · NCI · WASHINGTON UNIVERSITY · PI MICHALSKI, JEFF M. · 1999 to 2013
$22.8M
NCI NIH HHS CA10953NCI NIH HHS CA29511NCI NIH HHS U10 CA010953NCI NIH HHS U10 CA029511NCI NIH HHS U24 CA081647NCI NIH HHS U24 CA81647
6 · The paper itself

Abstract

Central review of radiation therapy (RT) delivery within multicenter clinical trials was initiated in the early 1970s in the United States. Early quality assurance publications often focused on metrics related to process, logistics, and timing. Our objective was to review the available evidence supporting correlation of RT quality with clinical outcomes within cooperative group trials. A MEDLINE search was performed to identify multicenter studies that described central subjective assessment of RT protocol compliance (quality). Data abstracted included method of central review, definition of deviations, and clinical outcomes. Seventeen multicenter studies (1980-2012) were identified, plus one Patterns of Care Study. Disease sites were hematologic, head and neck, lung, breast, and pancreas. Between 0 and 97% of treatment plans received an overall grade of acceptable. In 7 trials, failure rates were significantly higher after inadequate versus adequate RT. Five of 9 and 2 of 5 trials reported significantly worse overall and progression-free survival after poor-quality RT, respectively. One reported a significant correlation, and 2 reported nonsignificant trends toward increased toxicity with noncompliant RT. Although more data are required, protocol-compliant RT may decrease failure rates and increase overall survival and likely contributes to the ability of collected data to answer the central trial question.

Indexed as

Outcome Assessment, Health CareBreast NeoplasmsClinical Trials as TopicDisease-Free SurvivalFemaleHead and Neck NeoplasmsHematologic NeoplasmsHumansLung NeoplasmsMaleMulticenter Studies as TopicNeoplasmsPancreatic NeoplasmsPsychometricsQuality Assurance, Health CareRadiotherapy

Identifiers

PMID23683829
PMCPMC3749289

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.